20.15
-0.79%
Close of 20 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
Price performance
Chart by TradingView, with its own licensed prices
- Market value
- $415.1m
- Last close × shares
- Volume
- 166.4k
- Shares, 20 Nov 2026
About Shoulder Innovations
From its filings with the US Securities and Exchange Commission
Shoulder Innovations is based in Grand Rapids, Michigan and is incorporated in Delaware. Its shares trade on NYSE under the ticker SI. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $47.3m and a net loss of $40.4m. At that date it held total assets of $169.9m and shareholders' equity of $140.8m.
We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Our ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care. We believe our exclusive focus on shoulder surgical care, combined with a highly specialized commercial organization and strong clinical data, positions us well to capture significant share in this large, growing market.
Shoulder pain is highly prevalent, often chronic, and can significantly reduce quality of life. The primary conditions that can result in shoulder pain and reduced functionality include osteoarthritis, rheumatoid arthritis, rotator cuff tears and shoulder fractures. These shoulder conditions are widespread, often debilitating, and are commonly experienced concurrently as interrelated musculoskeletal disorders.
Quoted from its 10-K, filed 10 Mar 2026. Read the filing on SEC.gov ↗
Latest on Shoulder Innovations
Our reporting
- Shoulder Innovations falls 3.83% in Thursday's session
- Shoulder Innovations rises 2.19% in Tuesday's session
- Shoulder Innovations rises 4.48% in Monday's session
- Shoulder Innovations falls 6.41% in Friday's session
- Shoulder Innovations rises 2.12% in Thursday's session
- Shoulder Innovations rises 2.80% in Thursday's session
Next results
Due on 9 Mar 2027. Analysts expect earnings of -0.47 a share.
Other Health Care listings
Scenario calculator
Try your own numbers. This is arithmetic, not a forecast.
Gain or loss
Return
Leaves out fees, taxes and financing.
Frequently asked questions
What is Shoulder Innovations's ticker?
Shoulder Innovations trades as SI on its US listing, under ISIN US82537J1088.
What was Shoulder Innovations's last closing price?
20.15 on 20 Nov 2026. The figure is in USD and is never converted.
When does Shoulder Innovations next report results?
Results are expected on 5 Nov 2026, according to our data supplier.
Sources and methodology
- Chart
- TradingView
- Close and company data
- SEC filings and our data supplier
- News
- Our reporting
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.